- Home
- VALU vs HRTX Comparison
VALU vs HRTX Comparison
Compare VALU & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- HRTX
- Stock Information
- Founded
- VALU 1931
- HRTX 1983
- Country
- VALU United States
- HRTX United States
- Employees
- VALU N/A
- HRTX N/A
- Industry
- VALU Investment Managers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- HRTX Health Care
- Exchange
- VALU Nasdaq
- HRTX Nasdaq
- Market Cap
- VALU 384.1M
- HRTX 325.0M
- IPO Year
- VALU N/A
- HRTX 1987
- Fundamental
- Price
- VALU $38.80
- HRTX $2.00
- Analyst Decision
- VALU
- HRTX Strong Buy
- Analyst Count
- VALU 0
- HRTX 2
- Target Price
- VALU N/A
- HRTX $5.50
- AVG Volume (30 Days)
- VALU 2.5K
- HRTX 1.3M
- Earning Date
- VALU 07-25-2025
- HRTX 05-06-2025
- Dividend Yield
- VALU 3.40%
- HRTX N/A
- EPS Growth
- VALU 17.96
- HRTX N/A
- EPS
- VALU 2.28
- HRTX N/A
- Revenue
- VALU $35,695,000.00
- HRTX $148,518,000.00
- Revenue This Year
- VALU N/A
- HRTX $12.60
- Revenue Next Year
- VALU N/A
- HRTX $13.66
- P/E Ratio
- VALU $16.98
- HRTX N/A
- Revenue Growth
- VALU N/A
- HRTX 12.43
- 52 Week Low
- VALU $32.94
- HRTX $1.04
- 52 Week High
- VALU $57.68
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- VALU 47.12
- HRTX 50.55
- Support Level
- VALU $38.15
- HRTX $1.82
- Resistance Level
- VALU $39.50
- HRTX $1.93
- Average True Range (ATR)
- VALU 0.65
- HRTX 0.09
- MACD
- VALU -0.11
- HRTX 0.02
- Stochastic Oscillator
- VALU 34.98
- HRTX 75.00
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.